4d Pharma Share Discussion Threads

[podium] 25/6/2022 14:27

It does have the feint whiff of an orchestrated rinsing of the shareholders to get the company assets for next to nothing.

[fatgreek] 25/6/2022 14:26

I think it is a hostage situation. They knew shareholders didn't want 100 percent dilution. Bully them get it this way. Shareholders will now accept 200 percent.

[fatgreek] 25/6/2022 14:25

We are meant to have 7.5 mill still so it's not even 12.5

[fatgreek] 25/6/2022 14:25

Isn't it in oxfords interest to get this fixed"4D pharma has also granted Oxford Finance a warrant, exercisable for five years from today, to subscribe for 212,568 new ordinary shares in the Company at $1.18 per share. Further warrants will be granted to Oxford Finance as further tranches are drawn down."

[fatgreek] 25/6/2022 14:22

Many of us won't allow it

[amaretto1] 25/6/2022 14:15

Does any one have the name angle of the first person that on here mentioned the Oxford lean on DDDD ?

[amaretto1] 25/6/2022 14:13

I'm hoping Duncan is not involved with this !!

[amaretto1] 25/6/2022 14:12

This is orchestrated criminality!! They have off shored a huge short Collapsing the share price Making it impossible to raise !! Backed in to a corner ...With a lean on the IP and platform of 13 million .....U telling me we couldn't have done a fund raise for at least 20 million !! This is a HUR situation.....No way they getting away with this

[itsmean] 25/6/2022 14:11

So where does this leave us? We are like a big family and everyone gets on so well. It feels as we've been through a hostage situation together. Shall we all meet up at stone henge once a year? Why don't you try investing he said, 4D is a solid company he said. Another dissolved company for Dunc, chalk it up

[purchaseatthetop] 25/6/2022 14:11

Amaretto. Sorry to see your loss. Hopefully another share will cover it soon. Horrible for you.

[amaretto1] 25/6/2022 14:06

Money should have been raised months ago ... if this was the only option..... what were the advisers being paid for ??

[amaretto1] 25/6/2022 14:04

Or should say ... all the IP and Platform are trying to be taken for a fire sale price !! A complete set up ....This has been orchestrated for months .... the advisers to the company are either in on it ...Or completely inept at their job

[one_frankel] 25/6/2022 13:55

Tils still continues to stand to this very day YasX suprisingly and I too was ba_nned from LSE (and on numerous times!) when the 'Faithful' continued to avoid the blatantly obvious but what made it exciting was good old GCs audaciousness in presentations which 4D could have really utilised!

[stonerrj] 25/6/2022 13:42

yas...you don't read posts, you instead make a quick assumption as to what someone thinks.

"Undoubtedly you still probably think Oxford will waive the loan and advance further payments and that 4D will be back with a bid from Merck at ten times the price at which it was suspended."

Have you not read what I posted a little earlier? Quite the opposite if you actually pause to read and absorb.

Nor is this accurate:

"I told you there was no point in discussing the Oxford deal and further payments from it since none would be advanced - the Co. had tacitly conceded that in the announcement on 25.05.22. But, you insisted that they would and a placing was not required."

I actually stated, pretty consistently, that investors of pre-revenue companies like 4D should expect dilution and fundraising. It's what they do. I do not believe I have ever posted that 'a placing was not required'. My reference to the Oxford facility was only ever as a bridging facility that might get the company to either a) another milestone, dataset or value inflection point and/or b) an improvement in sentiment within the capital markets.

After all the Oxford deal had continued to be referenced by the BOD only recently, and in positive terms. No one was under any illusions as to what that kind of money could and couldn't achieve....further sources of funding would certainly be needed (and we discussed on here what those might or might not be, including a raise and subsequent dilution).

But sure, continue to state what I haven't and misrepresent me if it's so important to you.

Your missive above is just a long list of what you think the company should have done with hindsight.....which you have obviously made your best friend! The point I was making earlier is that I didn't see you raising a red flag or suggesting alternative actions at ANY point over the last year or so. Nor was there much disquiet amongst others when 4D announced the various points I listed earlier, such as going for a US listing, choosing a SPAC to do it, expanding the scope of the clinical trials, or indeed signing that Oxford deal.

The point is, you are not wrong in pointing to the various faults and mistakes that have been made. I think most would agree. But if you were as smart as I think you are desperate for everyone to think you are, you would have pointed to these errors a lot earlier than now. Nor did parroting the same thing sometimes, what, six or eight times a day do you any favours.

Anyway.

Stating that it's a certainty that I still think things will come good just goes to show how little you read and how prepared you are to paint someone else as you wish, if only to highlight your own excellence.

So be it.

[one_frankel] 25/6/2022 13:39

George, near enough every one of those points relate in some way to blatant incompetence of 4D management and utter disregard of shareholders...

But maybe management were incredibly ill-advised as to Oxford Finance and didn't really understand their contractual obligations or it could have been just plain short-sightedness of DP believing they were heading towards great things and existing covenants wouldn't be an issue in future...

...Absolutely Oliveria's selling wasnt done to achieve best price but we can only speculate as to how commercially viable his enterprise really was and whether he had no other option.

...4D had some truly memorable momentum upon that 518 release George before the selling commenced and it is invariably the case with relatively early stage growth in BioPharma that price action is rarely sustainable as its still far from any fruition and for management having contingency, hmmm, I doubt they had anything except for over expecting and under delivering...

But George, I completely understand the frustration and possibly the anger with those losses one may have but dont worry, opportunities will arise again when you least expect to redeem yourself as theres always some triumph after 'Having the rug literally pulled from beneath your feet' with all this utter madness buddy!

[yasx] 25/6/2022 13:33

Before I head off, if the technology is as valuable as he claims, why can't the Co. sell parts of it for a thick sum, pay off OF and restore the Co. as a solvent entity with sufficient working capital?

The reality is the tech is at a nascent stage, requires much more cash to develop it to anything close to a meaningful commercial proposition to potential bidders.

[georgethefourth] 25/6/2022 13:33

If they knew they had to have 7.5m in an account, or a placing by end of March, in order to meet the covenants of the OF loan why did they not raise in April when the 518 news came out? You’d have thought they’d have had sleepless nights worrying about it and knowing that it was last chance saloon - either raise on the 518 results (regardless of share price) or were in real trouble. Thing that gets me is that they could have raised on the back of those results and it would have worked out. So why didn’t they? Blaming incompetence doesn’t seem plausible really. You know you’re in breach of terms and HAVE to raise. There is no alternative. They couldnt have been so incompetent as to not realise this and, having realised this, they couldn’t just stick their heads in the sand and do nothing. No one is that incompetent. So either they couldn’t get a placing away, or it was planned

[yasx] 25/6/2022 13:26

Purchase,

Quite.

It is absurd to suggest that, assuming the technology is as robust as claimed, they could not have secured such a paltry sum in the summer of 21 (the shares were around 100p) by way of a discounted placing.

They signed up to this on egregious terms and very shortly after Beck died. Something does not add up.

It is audacious for Peyton to aver on the presentation that 4D's tech is far better than that of another Co. which just got a bid tabled at 1.6 BLN. If he sincerely thought that, why did he sign away these assets for a pittance (essentially £4M as you point out).

I think Peyton has likely not been fully transparent with shareholders and he has certainly been incompetent. I of course assume there has been no spurious behaviour. I therefore assume he is just grossly incompetent - but then so too the rest of his 'focused and diligent' management team. What was the new CFO thinking? Are they really all that useless not to even grasp the basics. Even a couple of days ago Peyton was on the call stating his vision was becoming a reality. Not a slip I hope.....

I make no allegations - merely speculating.

[nigelpm] 25/6/2022 13:22

Looking in that point further I'd guess they never deposited the required $7.5m into that collateral account.

[purchaseatthetop] 25/6/2022 13:19

Yasx. The extraordinary thing is that they got $12.5m in July 21 but had to have $7.5m in a collateral US account by 31/3/22 so only really got $5m which is two months operating costs. They put the whole company at risk for £4m!

They had £20.7m cash on 30/6/21 so they still had 9 months cash reserve.

There are only two possible explanations.
1) Utter board incompetence and desperation for funding and they did not care where they got it from, or
2) This has been planned from the getgo and PI were set up like patsies to lose everything.